To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation

This study has been completed.

Study NCT00189319 Information provided by MEDA Pharma GmbH & Co. KG

First Received: September 13, 2005 Last Updated: February 20, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given